Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
QIAGEN N.V. (QGEN), most recent 12 months reported: revenue $2.09B, net income $424.88M, free cash flow $453.28M. Latest balance sheet on file: liquid cash $1.1B, total debt $1.65B, net cash -$555.51M. From SEC filings. More on QIAGEN N.V.: Revenue · Profitability · Cash flow · Debt · Dividends Others in Biological Products, (No Diagnostic Substances): BIOGEN INC. · NEUROCRINE BIOSCIENCES INC · Exelixis Inc · Moderna, Inc. · HALOZYME THERAPEUTICS, INC. · BIO-TECHNE Corp · BIOCRYST PHARMACEUTICALS, INC. · REPLIGEN CORP
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.